Syon Capital LLC bought a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund bought 9,959 shares of the financial services provider’s stock, valued at approximately $1,848,000.
Several other hedge funds have also recently modified their holdings of MRSH. Capital International Investors acquired a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at about $3,482,557,000. Capital World Investors acquired a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at about $3,140,284,000. Norges Bank acquired a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at about $1,555,869,000. Capital Research Global Investors acquired a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at about $1,481,896,000. Finally, Goldman Sachs Group Inc. acquired a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at about $744,740,000. Institutional investors and hedge funds own 87.99% of the company’s stock.
Marsh & McLennan Companies Trading Down 0.0%
Shares of NYSE MRSH opened at $165.37 on Monday. The company has a market capitalization of $79.89 billion, a P/E ratio of 20.67, a PEG ratio of 2.41 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $231.36. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11.
Insider Buying and Selling
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. This represents a 12.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the stock. Morgan Stanley cut their price objective on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating on the stock in a report on Monday, April 6th. Wells Fargo & Company cut their price objective on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a report on Thursday, April 9th. JPMorgan Chase & Co. dropped their target price on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a research report on Thursday, April 9th. Weiss Ratings lowered Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Finally, Raymond James Financial upgraded Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 target price on the stock in a research report on Tuesday, February 17th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $203.56.
View Our Latest Analysis on Marsh & McLennan Companies
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Further Reading
- Five stocks we like better than Marsh & McLennan Companies
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
